Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-10T07:56:40.600Z Has data issue: false hasContentIssue false
  • English
  • Français

Post-transplant lymphoproliferative disease is associated with early sternotomy and left ventricular hypoplasia during infancy: a population-based retrospective review

Published online by Cambridge University Press:  07 August 2017

Britt-Marie Ekman-Joelsson Open the ORCID record for Britt-Marie Ekman-Joelsson [Opens in a new window] ,
Håkan Wåhlander ,
Mats Synnergren ,
Madeleine Sager  and
Karin Mellgren
Britt-Marie Ekman-Joelsson*
Affiliation:
Department of Pediatrics, Institution for Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Håkan Wåhlander
Affiliation:
Department of Pediatrics, Institution for Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Mats Synnergren
Affiliation:
Department of Pediatrics, Institution for Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Madeleine Sager
Affiliation:
Södra Älvsborg Hospital, Borås, Sweden
Karin Mellgren
Affiliation:
Department of Pediatrics, Institution for Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
*
Correspondence to: B.-.M. Ekman-Joelsson, The Queen Silvia Children’s Hospital, Gothenburg 416 50, Sweden. Tel: +46 31 343 8377; Fax: +46 3 184 5029; E-mail: britt-mari.ekman-joelsson@vgregion.se
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Heart transplantation has been an option for children in Sweden since 1989. As our unit faced an increased rate of post-transplant lymphoproliferative disorder, the objective of the study was to identify possible risk factors.

Methods

This is a retrospective study of all children aged 0–18 years who underwent heart transplantation in Gothenburg from 1989 to 2014.

Results

A total of 71 children underwent heart transplantation. The overall incidence of post-transplant lymphoproliferative disorder was 14% (10/71); however, 17% (6/36) of those undergoing transplantation after 2007 developed lymphoma, compared with only 10% (4/35) of transplantation cases before 2007 (p=0.85). The mean age at transplantation was 9 years (0–17). The mean post-transplant follow-up time was 5.5 years (0.5–21.9) in the group that developed post-transplant lymphoproliferative disorder, compared with 10.2 years (0.02–25.2) in those who did not. In our study group, risk factors for post-transplant lymphoproliferative disorder were surgically palliated CHD (p=0.0005), sternotomy during infancy (p⩽0.0001), hypoplastic left ventricle (p=0.0001), number of surgical events (p=0.0022), mismatch concerning Epstein–Barr virus infection – that is, a positive donor–negative recipient (p⩽0.0001) – and immunosuppressive treatment with tacrolimus compared with ciclosporine (p=0.028).

Discussion

This study has three major findings. First, post-transplant lymphoproliferative disorder only developed in subjects born with CHD. Second, the vast majority (9/10) of the subjects developing the disorder had undergone sternotomy as infants. Third, the number of surgical events correlated with a higher risk for developing post-transplant lymphoproliferative disorder.

Keywords

Heart transplantationchildpost-transplant lymphoproliferative diseasesternotomyCHD
Type
Original Articles
Information
Cardiology in the Young , Volume 27 , Issue 9 , November 2017 , pp. 1823 - 1831
Check for updates
Copyright
© Cambridge University Press 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Dipchand, AI, Edwards, LB, Kucheryavaya, AY, et al. The registry of the International Society for Heart and Lung Transplantation: seventeenth official pediatric heart transplantation report-2014. J Heart Lung Transpl 2014; 33: 985–995.Google Scholar
2. Gajarski, RJ, Blume, ED, Urschel, S, et al. Infection and malignancy after pediatric heart transplantation: the role of induction therapy. J Heart Lung Transplant 2011; 30: 299–308.Google Scholar
3. Paya, CV, Fung, JJ, Nalesnik, MA, et al. Ebstein-Barr virus-induced posttransplant lymphoproliferative disorders. Transplantation 1999; 68: 1517–1525.CrossRefGoogle Scholar
4. Webber, SA, Naftel, DC, Fricker, FJ, et al. Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study. Lancet 2006; 367: 233–239.Google Scholar
5. Manlhiot, C, Pollock-Barziv, SM, Holmes, C, et al. Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients. J Heart Lung Transplant 2010; 29: 648–5720.CrossRefGoogle ScholarPubMed
6. Vanderlaan, RD, Manlhiot, C, Edwards, LB, Conway, J, McCrindle, BW, Dipchand, AI. Risk factors for specific causes of death following pediatric heart transplant: an analysis of the registry of the International Society of Heart and Lung Transplantation. Pediatr Transplant 2015; 19: 896–905.Google Scholar
7. Gilljam, T, Higgins, T, Bennhagen, R, Wåhlander, H. First two decades of paediatric heart transplantation in Sweden – outcome of listing and post-transplant results. Acta Paediatrica 2011; 100: 1442–1447.Google Scholar
8. Hetzer, R, Weng, Y, Walter, EMD. State of the art in paediatric heart transplantation: the Berlin experience. Eur J Cardio-Thorac Surg 2013; 43: 258–267.Google Scholar
9. Greutmann, M, Pretre, R, Furrer, L, et al. Heart transplantation in adolescent and adult patients with congenital heart disease: a case-control study. Transpl Proc 2009; 41: 3821–3826.Google Scholar
10. Chinnock, RE, Bailey, LL. Heart transplantation for congenital heart disease in the first year of life. Curr Cardiol Rev 2011; 7: 72–84.Google Scholar
11. Voeller, RK, Epstein, DJ, Guthrie, TJ, Gandhi, SK, Canter, CE, Huddleston, CB. Trends in the indications and survival in pediatric heart transplants: a 24-year single-center experience in 307 patients. Ann Thorac Surg 2012; 94: 807–816.CrossRefGoogle ScholarPubMed
12. Finn, A, Naik, S, Klein, N, Levinsky, RJ, Strobel, S, Elliott, M. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 105: 234–241.Google Scholar
13. Brix-Christensen, V. The systemic inflammatory response after cardiac surgery with cardiopulmonary bypass in children. Acta Anaesthesiol Scand 2001; 45: 671–679.CrossRefGoogle ScholarPubMed
14. Adrian, K, Skogby, M, Gatzinsky, V, Friberg, LG, Mellgren, K. Procedure-induced inflammation and endothelial cell activation in an artificially ventilated and circulated porcine double-lung model. Artif Organs 2006; 12: 922–928.Google Scholar
15. Halnon, NJ, Jamieson, B, Plunkett, M, Kitchen, MR, Pham, T, Krogstad, P. Thymic function and impaired maintenance of peripheral T cell populations in children with congenital heart disease and surgical thymectomy. Pediatr Res 2005; 57: 42–48.Google Scholar
16. Afifi, A, Raja, SG, Pennington, DJ, Tsang, VT. For neonates undergoing cardiac surgery does thymectomy as opposed to thymic preservation have any adverse immunological consequences? Interact Cardiovasc Thorac Surg 2010; 11: 287–291.Google Scholar
17. Gudmundsdottir, J, Oskarsdottir, S, Skogberg, G, et al. Early thymectomy leads to premature immunologic ageing: an 18-year follow-up. J Allergy Clin Immunol 2016; 138: 1439–1443.CrossRefGoogle ScholarPubMed
18. Ferrnado-Martinez, S, Munoz-Fernandes, MA, Leal, M. Perioperative Considerations in Cardiac Surgery. InTech, Shanghai, 2012, 339pp.Google Scholar
19. Benden, C, Aurora, P, Burch, M, et al. Monitoring of Epstein–Barr viral load in pediatric heart and lung transplant recipients by real-time polymerase chain reaction. J Heart Lung Transpl 2005; 24: 2103–2108.Google Scholar
20. Hayes, D Jr, Breuer, CK, Horwitz, EM, Yates, AR, Tobias, JD, Shinoka, T. Influence of posttransplant lymphoproliferative disorder on survival in children after heart transplantation. Pediatr Cardiol 2015; 36: 1748–1753.Google Scholar
21. Kumarasinghe, G, Lavee, O, Parker, A, et al. Post-transplant lymphoproliferative disease in heart and lung transplantation: defining risk and prognostic factors. J Heart Lung Transplant 2015; 34: 1406–1414.Google Scholar
22. Chinnock, R, Webber, SA, Dipchand, AI, Brown, RN, George, JF, and the Pediatric Heart Transplant Study. A 16-year multi-institutional study of the role of age and EBV status on PTLD incidence among pediatric heart transplant recipients. Am J Transplant 2012; 12: 3061–3068.Google Scholar
23. Allen, UD, Preiksaitis, JK, and the AST Infectious Diseases Community of Practice. Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation. Am J Transplant 2013; 13: 107–120.Google Scholar
24. Green, M, Michaels, MG. Epstein-Barr virus infection and posttransplant lymphoproliferative disorder. Am J Transplant 2013; 13: 41–54.CrossRefGoogle ScholarPubMed
25. Carpentier, L, Tapiero, B, Alvarez, F, Viau, C, Alfieri, C. Epstein-Barr virus (EBV) early-antigen serologic testing in conjunction with peripheral blood EBV DNA load as a marker for risk of posttransplantation lymphoproliferative disease. J Infect Dis 2003; 188: 1853–1864.Google Scholar
26. Schubert, S, Abdul-Khaliq, H, Lehmkuhl, HB, et al. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients. Pediatr Transplant 2009; 13: 54–62.Google Scholar
27. Gao, SZ, Chaparro, SV, Perlroth, M, et al. Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University. J Heart Lung Transplant 2003; 22: 505–514.CrossRefGoogle ScholarPubMed
28. Seal, A, Hawkes, M, Bhargava, R, et al. Radiation exposure from diagnostic imaging in a cohort of pediatric transplant recipients. PLoS One. 2017; 12: 1–10.Google Scholar
29. Richardson, DB, Sugiyama, H, Wing, S, et al. Positive associations between ionizing radiation and lymphoma mortality among men. Am J Epidemiol 2009; 169: 969–976.Google Scholar